Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets – USD ($)
Oct. 31, 2022
Jul. 31, 2022
Current assets    
Cash and cash equivalents $ 5,729,691  $ 12,299,740 
Prepaid expenses and other current assets 2,903,468  2,932,731 
Total Current Assets 8,633,159  15,232,471 
Property and equipment, net 933,701  978,614 
Intangible assets, net 361,059  378,529 
Operating lease right-of-use assets 3,931,083  4,665,515 
Other long-term assets 579,960  623,239 
Total Assets 14,438,962  21,878,368 
Current liabilities    
Accounts payable and accrued liabilities 4,802,456  4,208,222 
Accrued compensation related 468,618  376,977 
Operating lease liabilities 978,570  1,111,571 
Note payable 659,870  936,558 
Total Current Liabilities 6,909,514  6,633,328 
Operating lease liabilities, net of current portion 3,513,897  4,126,636 
Liability under co-promotion agreement – related party 5,000,000  5,000,000 
Total Liabilities 15,423,411  15,759,964 
Stockholders’ Equity (Deficit)    
Common stock authorized – 4,545,455 common shares with a par value of $0.0001 as of October 31, 2022 and July 31, 2022, common stock issued and outstanding – 1,790,741 and 1,790,051 common shares as of October 31, 2022 and July 31, 2022, respectively 179  179 
Additional paid-in capital 288,767,020  288,236,945 
Warrants issued and outstanding – 75,897 and 77,554 warrants as of October 31, 2022 and July 31, 2022, respectively 3,368,509  3,591,734 
Accumulated other comprehensive income 898,906  247,211 
Accumulated deficit (294,019,063)  (285,957,665) 
Total Stockholders’ Equity (Deficit) (984,449)  6,118,404 
Total Liabilities and Stockholders’ Equity (Deficit) $ 14,438,962  $ 21,878,368